Skip to Content

M 14 (Methotrexate 2.5 mg)

Pill with imprint M 14 is Orange, Round and has been identified as Methotrexate sodium 2.5 mg. It is supplied by Mylan Pharmaceuticals Inc..

Methotrexate is used in the treatment of rheumatoid arthritis; psoriatic arthritis; psoriasis; acute lymphocytic leukemia; acute lymphoblastic leukemia (and more), and belongs to the drug classes antimetabolites, antipsoriatics, antirheumatics, other immunosuppressants. Not for use in pregnancy. Methotrexate 2.5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for M 14

Methotrexate sodium 2.5 mg M 14
Methotrexate sodium 2.5 mg M 14  Front
Methotrexate sodium 2.5 mg M 14  Back
Methotrexate sodium 2.5 mg M 14

Methotrexate sodium

M 14
2.5 mg
6.00 mm
Prescription only
Drug Class:
Other immunosuppressants
Pregnancy Category:
X - Not for use in pregnancy
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Mylan Pharmaceuticals Inc.
Inactive Ingredients:
silicon dioxide
lactose monohydrate
magnesium stearate
microcrystalline cellulose
corn starch
sodium carbonate monohydrate
sodium lauryl sulfate
sodium starch glycolate type A potato
FD&C Red No. 40
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
51079-0670 UDL Laboratories Inc.

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.